PTC 209
Chemical Name: N-(2,6-Dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)-2-thiazolamine
Purity: ≥98%
Biological Activity
PTC 209 is a Bmi-1 inhibitor (IC50 ~ 0.5 μM); irreversibly impairs colorectal cancer-initiating cell (CIC) growth. Reduces tumor growth in CIC xenograft assays and results in reduced potential of colorectal cancer cells to initiate tumors in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Self-renewal as a therapeutic target in human colorectal cancer.
Kreso et al.
Nat.Med., 2014;20:29
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for PTC 209
The citations listed below are publications that use Tocris products. Selected citations for PTC 209 include:
2 Citations: Showing 1 - 2
-
Inverse and reciprocal regulation of p53/p21 and Bmi-1 modulates vasculogenic differentiation of dental pulp stem cells.
Authors: Zhaocheng Et al.
Cell Death Dis 2021;12:644
-
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
Authors: Yan Et al.
Cancer Cell 2019;36:139-155.e10
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for PTC 209
There are currently no reviews for this product. Be the first to review PTC 209 and earn rewards!
Have you used PTC 209?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image